Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

This year’s prestigious Lasker medical awards recognize a trio of scientists without whom Ozempic and other blockbuster weight-loss drugs might not exist. The work of Joel Habener, a physician-investigator at the Mass General Research Institute and Harvard Medical School professor;

James Chen, a professor of microbiology at UT Southwestern Medical Center, has won a Lasker Award for his discovery of an enzyme involved in immune response.

F ROM LOS ANGELES to London, weight-loss drugs such as Ozempic are reshaping culture as much as waistlines. Some Ozempic-takers have tiny appetites and dine at unusual hours to avoid spells of nausea.

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so what was that journey like for the scientists involved?

Weight-loss drugs like Ozempic are booming in popularity, but experts warn they aren't silver bullets for obesity.